Respiratory oxygen delivery devices market seen reaching $25.69B by 2030

The respiratory oxygen delivery devices market is projected to grow from $16.53 billion in 2025 to $18.26 billion in 2026, then reach $25.69 billion by 2030, according to The Business Research Company. Rising asthma cases, home healthcare demand and smarter oxygen systems are shaping the market’s next phase.

Why it matters: - Respiratory oxygen delivery devices are becoming more central to care as chronic respiratory disease, hypoxemia and aging populations drive higher oxygen demand. - The market’s growth points to expanding need across hospitals, critical care, home healthcare and remote monitoring. - For suppliers, the shift toward portable and connected oxygen devices creates room for higher-value products and broader adoption.

What happened: - The Business Research Company released a Respiratory Oxygen Delivery Devices Market Report 2026 covering market size, trends and global forecasts through 2035. - The market is projected to rise from $16.53 billion in 2025 to $18.26 billion in 2026, a 10.5% CAGR. - The report forecasts the market will reach $25.69 billion by 2030, with an 8.9% CAGR over the forecast period. - Asia-Pacific was the largest regional market in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Respiratory oxygen delivery devices supply supplemental oxygen to patients who need help maintaining adequate oxygen levels. - The devices are used for conditions including COPD, pneumonia and other lung-related illnesses. - The market’s recent growth has been supported by rising chronic respiratory illness, more respiratory-related hospital admissions, expanded critical care facilities, an aging population and broader device availability. - The forecast period is expected to benefit from more remote patient monitoring, greater use of home healthcare, earlier diagnosis and management of respiratory disease, and more smart connected medical devices. - The report highlights wider use of high-flow oxygen systems, stronger demand for home-based oxygen therapy, smart oxygen monitoring features and lighter portable devices. - Asthma is a key market driver because flare-ups often require oxygen support to improve breathing and lung function. - The National Asthma Council of Australia reported 474 asthma-related deaths in 2023, compared with 473 in 2022. - The report’s 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics, key technologies and future trends, plus updated graphics and tables. - The company invited readers to download a free sample and view the full report through the sample report and the full market report.

Between the lines: - The report suggests the market is moving from basic oxygen delivery toward more connected, home-friendly and patient-comfort-focused systems. - Persistent asthma burden and broader respiratory disease management needs are likely to keep demand steady even as technology changes the product mix. - Asia-Pacific’s lead signals that demand growth is not limited to North America and Europe, and suppliers may need region-specific strategies.

What's next: - The market is expected to keep expanding through 2030 as home healthcare, remote monitoring and smart oxygen devices gain traction. - Companies focused on lightweight, portable and connected systems may be best positioned to capture future demand. - The Business Research Company is offering report access and expert contact channels for buyers seeking deeper market detail.

The bottom line: - Respiratory oxygen delivery devices are moving into a higher-growth, more tech-enabled phase, with the market set to add billions of dollars over the next several years.